Translational Predictions
Epiloid predicts neurological drug efficacy using brain organoids with 94% accuracy
Translational Predictions
Epiloid predicts neurological drug efficacy using brain organoids with 94% accuracy
Translational Predictions
Epiloid predicts neurological drug efficacy using brain organoids with 94% accuracy
Our models accurate identify useful therapeutics
Our models accurate identify useful therapeutics
By combining human brain organoids of disease with machine learning analysis, Epiloid transforms the way drug efficacy is measured for neurological conditions like epilepsy and Parkinson’s.
Our technology delivers human-relevant results at the pre-clinical stage, accelerating the path to effective treatments. We've been able to successfully classify 94% of drug-treated organoids on their use as a hypoexcitable therapeutic, for use in treating diseases like Epilepsy.
By combining human brain organoids of disease with machine learning analysis, Epiloid transforms the way drug efficacy is measured for neurological conditions like epilepsy and Parkinson’s.
Our technology delivers human-relevant results at the pre-clinical stage, accelerating the path to effective treatments. We've been able to successfully classify 94% of drug-treated organoids on their use as a hypoexcitable therapeutic, for use in treating diseases like Epilepsy.
